peptide ss 31 mitochondrion-targeted peptide SS-31 - SS-31peptidedosage SS-31肽是一种心磷脂过氧化物酶抑制剂和线粒体靶向肽 Unveiling the Potential of Peptide SS-31: A Mitochondria-Targeting Antioxidant

SS-31peptidedosage chart The scientific community is increasingly focused on peptide SS-31, a groundbreaking mitochondria-targeting peptide that is showing immense promise in various therapeutic applications. This small, synthetic molecule, also known by its development codes SS-31, MTP-131, and the brand name Elamipretide, is designed to accumulate within mitochondria, the powerhouses of our cells, offering targeted protection and functional enhancement.

At its core, peptide SS-31 functions as a potent antioxidant. It is a mitochondria-targeted antioxidant peptide capable of actively scavenging reactive oxygen species (ROS), which are unstable molecules that can cause significant cellular damage, particularly to mitochondria. This antioxidant peptide works by inhibiting cytochrome c peroxidase, playing a crucial role in mitigating oxidative stress. The mechanism involves SS-31 accumulating in mitochondria and directly scavenging ROS, thereby protecting cellular components from damage.

The precise amino acid sequence of SS-31 peptide contributes to its unique ability to interact with mitochondrial membranes. Research indicates that SS-31 alters divalent cation (calcium) distribution within these membranes, potentially reducing the energetic burden associated with calcium stress. This interaction is vital for maintaining mitochondrial integrity and function. One of its key attributes is its role as a cytochrome c peroxidase inhibitor, further contributing to its antioxidant capabilities作者：D Liu·2019·被引用次数：158—SS-31, as a mitochondria-targeted peptide with strong antioxidant activity,is a good candidate for the treatment of AKI. However, an efficient treatment of AKI ....

SS-31 peptide has demonstrated significant protective benefits across a range of physiological systems. Studies suggest it offers protective benefits on glomerular mitochondria, even with short-term administration, leading to temporal changes in glomerular architecture作者：JD Chavez·2020·被引用次数：176—SS-31 is a synthetic peptide that improves mitochondrial functionand is currently undergoing clinical trials for treatments of heart failure, .... This underscores its potential in kidney health. Furthermore, SS-31 has shown efficacy in models of acute kidney injury (AKI), where it is considered a good candidate for the treatment of AKI due to its ability to reduce elevated levels of ROS stemming from mitochondrial dysfunction.The antioxidant peptide SS31 prevents oxidative stress ...

Beyond kidney health, the therapeutic applications of peptide SS-31 extend to cardiovascular health. Research in animal models has indicated that SS-31 administration reduced the area and sizes of western diet-induced atherosclerotic plaques and positively altered their composition.Mitochondrial protein interaction landscape of SS-31 It has also shown beneficial effects on improving cardiac mitochondrial dysfunction in models of Barth syndrome, suggesting its potential as a treatment for Barth syndrome.SS-31 Patient Information.docx In fact, Elamipretide (a name under which SS-31 is developed) is a medication used for the treatment of Barth syndrome.SS31

The impact of SS-31 on cognitive function and neuroprotection is another area of active investigation.Elamipretide/SS-31 (discontinued due to IP conflict) 多肽 SS-31 emerges as a promising therapeutic candidate to attenuate neurodegeneration pertinent to alpha-synuclein misfolding and aggregation. Its benefits are also being explored in conditions like diabetes, where it may help mitigate mitochondrial dysfunction and oxidative stress related to diabetic nephropathy.

The synthetic nature of SS-31 is noteworthy. It is described as a synthetic tetrapeptide meticulously developed to specifically target and protect mitochondria作者：X Du·2024·被引用次数：41—SS-31 demonstrates remarkable efficacy in reducing elevated levels of reactive oxygen species(ROS) resulting from mitochondrial dysfunction. In Table 1, .... Its efficacy is further highlighted by its ability to improve mitochondrial function.作者：D Liu·2019·被引用次数：158—SS-31, as a mitochondria-targeted peptide with strong antioxidant activity,is a good candidate for the treatment of AKI. However, an efficient treatment of AKI ... In instances of mitochondrial disorders, such as mitochondrial cardiomyopathy, SS-31 peptide reverses the mitochondrial fragmentation present in fibroblasts, suggesting a reparative role at the cellular level2025年9月10日—Explore howSS-31 targets mitochondriato boost ATP, reduce oxidative stress, and support recovery. Benefits, mechanisms, dosing, safety, ....

While early research is highly promising, it's important to note that SS-31 is still undergoing clinical trials for various conditions, including heart failure. The development of pharmaceutical-grade mitochondria-targeting peptide formulations aims to ensure optimal delivery and therapeutic outcomes. Emerging research also explores its impact on cellular repair and anti-aging processes, positioning SS-31 as a molecule with broad potential for enhancing cellular energy production and overall well-being.

It is crucial for individuals considering SS-31 peptide for any health-related purpose to consult with qualified healthcare professionals. Information on SS-31 peptide benefits, potential SS-31 peptide side effects, and appropriate SS-31 peptide dosage should be obtained from reliable sources and discussed with medical experts. While SS-31 peptide for sale may be available, the focus remains on its therapeutic potential through well-regulated research and clinical application. The continued exploration of SS-31 and its mitochondrial repair capabilities holds significant promise for addressing a wide spectrum of age-related and disease-specific challenges.作者：H Zhao·2017·被引用次数：80—We demonstrated that treatment with themitochondrion-targeted peptide SS-31reduced frataxin deficiency-induced oxidative stress in lymphoblasts and ...

Key Entities and LSI:

* Peptide SS-31

* Mitochondria-targeting peptide

* Antioxidant

* ROS (Reactive Oxygen Species)

* Mitochondrial function

* Elamipretide

* MTP-131

* Barth Syndrome

* AKI (Acute Kidney Injury)

* Glomerular mitochondria

* Cardiac mitochondrial dysfunction

* Neurodegeneration

* Alpha-synuclein

* Cytochrome c peroxidase inhibitor

* Calcium distribution

* Cellular repair

* ATP production